Automated Patch Clamping Trends 2014

Publisher Name :
Date: 17-Apr-2014
No. of pages: 54

Executive Summary

  • This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on ion channel drug screening using automated patch clamping (APC) technology carried out in March 2014.
  • The study was initiated by HTStec as part of its ongoing tracking of life science marketplaces. The questionnaire was compiled to meet the needs and interests of ephys/APC vendor community.
  • The objective of this global benchmarking study was to comprehensively document current practices, preferences and metrics in ion channel drug screening using APC technology. It also seeks to chart the emergence of new 384-well APC systems, what determines APC consumable budgets, and most prevents end-users making greater use of APC consumables. In addition, a secondary focus was to understand respondents’ interests and requirements in using a new APC technology for the analysis of adherent cellular 2D networks.
  • Equal emphasis was given to soliciting opinion from Pharma, Other Screening Labs and Academic Research segments in North America, Europe and Japan.
  • The survey looked at the following aspects of ion channel screening using APC technology, as practiced to date (2014) and in some cases as predicted for the future (2016): ion channels classes of greatest interest; ion channels that have proved most difficult to run as primary screens; number of ion channel programs investigated; primary drivers for initiating a new ion channel programs; areas of drug discovery applying APC technologies; typical size of the compound library in drug discovery areas using an APC platform; number of APC patch wells expected to processed per year; proportion of APC assays using different cell types; current access to APC ion channel platforms; preferred vendor’s APC systems for different criteria; likelihood of purchasing a new APC platform over the next few years; factors that most influence a decision to purchase a particular APC platform; APC consumables budget for ion channel screening and how they are determined; what factors most prevent making greater use of APC consumables today; whether the recent introduction of new 384-well APC screening platforms will affect screening activities; prohibitive and stimulative 384-well APC consumable pricepoints; and awareness of the FDA CIPA working group and its potential impact on safety assays undertaken. With respect to a new APC system for adherent 2D cellular networks the following were investigated: technologies already used to obtain information on cell-cell communication within cellular 2D networks; what respondents most want to analyze with the system; applications most suited to the system; cell types most likely to be used with the system; main advantages of the system; impact of the potential disadvantages of the system; features essential for the adoption and exploitation of the system; optimal patch combinations; usefulness of the potential throughput likely to be achieved with the system; preferred routes to access and fit to existing workflow of the system; reasonable price to pay for the APC system; likelihood of future purchasing of the system; reasonable APC consumable pricing for the system; and interest to receive more information/testing of the system.
  • The survey questionnaire consisted of 32 mainly multi-choice questions. In addition, there were 6 questions related solely to survey demographics.
  • The survey collected 88 validated responses, of these 63% provided comprehensive input.
  • Survey responses were geographically split: 34% North America; 31% Europe; 30% Japan; 2% China; 2% Rest of World; and 1% India.
  • Survey respondents were drawn from persons or groups actively involved in ion channel screening, selectivity profiling and safety assessment against ion channel liabilities using APC systems.
  • Respondents represented: 20 Medium-Small Pharma; 17 University/ Research Institute/Government Labs/ Not-for-Profit; 16 Large Pharma; 15 Biotech Company; 9 Contract Research Organisation; 6 Biopharma; 2 Academic Screening Center; 1 Agrochemical/Agri-Biotech Company; 1 Tobacco Company and 1 Other.
  • Most survey respondents had a senior job role or position which was in descending order: 20 research scientists/associates; 20 senior scientists/researchers; 12 principal investigators; 9 section/group leaders; 5 post-docs; 5 department heads; 5 directors; 4 lab managers; 4 professors/assistant professors; 2 vice presidents; and 2 others.
  • Survey results were expressed as an average of all survey respondents. In addition, where appropriate the data was reanalyzed after sub-division into the following 6 survey groups: 1) Pharma; 2) Other Screening Labs; 3) Academic Research; 4) Europe; 5) North America; and 6) Japan.
  • The ion channel research activity most undertaken by respondents was secondary screening.
  • The class of ion channels of most interest was voltage-gated potassium channels. The class of ion channels most experienced difficulty running as primary screens was voltage-gated calcium channels.
  • A median of 3 ion channel programs were under investigation in respondent’s organisation.
  • The primary driver for initiating a new ion channel program was the disease focus of the company.
  • APC technologies were most used today for assay development and hits-to-leads (lead optimization).
  • The median compound library size tested using APC was: 1K-5K for primary screening/HTS; <1K for all hit-to-lead follow-up; and <1K for early non-compliant hERG liability testing.
  • The median number of APC wells processed/year was: 5K-10K for primary screening/HTS; 1K-5K for all hit-to-lead follow-up; and 1K-5K for early non-compliant hERG liability testing.
  • The cell type they most used for APC assays today was recombinant cell lines.
  • The most common APC system available for use in respondents’ labs was the Sophion QPatch 8, 16 or HT.
  • From current prevalence of APC instruments Molecular Devices & Sophion have the greatest vendor share.
  • Of a list of relevant criteria Molecular Devices was the preferred vendor’s APC system with respect cost per consumable, cost per data point and throughput. Sophion was the preferred vendor’s APC system with respect to the 11 other important criteria rated.
  • The median likelihood respondents will purchase a new APC platform over the next few years (by end of 2016) was low (<10% purchasing probability).
  • APC platforms currently most appealing for purchasing were Sophion Qube & Nanion Syncropatch 384PE.
  • The quality of the results was the factor which would most influence a decision to purchase a particular brand/model of APC platform.
  • The median annual APC consumable budget was $50K-$100K/year today.
  • Several bottom-up models were developed around the respondent’s feedback to calculate the global APC markets. In 2014 these were estimated to be around $140M for APC consumables and $38M for new APC platforms. Segmentation & some CAGR estimates are in the full report.
  • The APC consumable budget for ion channel testing of most respondents was not fixed i.e. it can be adjusted to reflect cost changes per data point.
  • The factors that most prevent greater use of APC consumables today were the high cost of APC consumables and lack of ion channel projects.
  • The most predicted effect of the introduction of new 384-well APC screening platforms was to increase the number of data points screened, but with a similar consumable budget.
  • For new 384-well APC screening platforms the median prohibitive pricepoint (i.e. limits use to certain applications & inhibits adoption) was $1.00 per APC data point and $350-$450 per 384-well patch plate.
  • The majority were aware of the FDA CIPA working group where the cardiac risk panel was questioned.
  • The most investigated technology to obtain information on cell-cell communication within a 2D cellular network was manual patch clamp.
  • A new APC system in development for the analysis whole-cell and cell-attached-measurements of individual cells (e.g. neural or cardiac) in an adherent cellular 2D network was presented. The following feedback was obtained with respect to the technology in general or to the proposed academic APC system: 1) analyzing more than one adherent cell from a network in parallel was rated where greatest interest resides; 2) analyzing neuronal networks in general was rated the most suitable application; 3) primary neurons and recombinant cell lines were the cell types most would like to investigate; 4) allows for analysis of cell-cell communication was ranked as the greatest advantage; 5) the need to invest in a new APC system to measure cellular 2D networks was rated the biggest limitation; 6) extracellular perfusion of the whole well was selected as the most essential feature for adopting and exploiting the system; 7) the most wanted patch combination was 100-150 μm patch-to-patch distance, 2 patch sites per chip; 8) the throughput detailed (10 networks per day) was moderately useful in all drug discovery areas, apart from primary screening/HTS; 9) the preferred route to access was via a fee-for-service provider as an addition to current patch-clamp techniques; 10) the median reasonable price was $100K per system; 11) the median probability of purchasing when it becomes available was overall low (<10%), but medium (10-50%) in academic labs; 12) the median reasonable price for an APC consumable was $100-$200 per single chip; and 13) 24 labs want to receive more information and 17 labs want to test the academic APC system. Feedback on the proposed pharmaceutical APC system is given the full report.
  • The full report provides the data, details of the breakdown of the responses for each question, its segmentation and the estimates for the future (2016). It also highlights some interesting differences between the survey groups.

Automated Patch Clamping Trends 2014 published by HTStec Ltd in 17 April 2014. This report consists of 54 Pages and the price starts from US $ 2500.

Automated Patch Clamping Trends 2014

Table of Contents

Executive Summary 2
Survey Methodology 5
Respondent’s Organisation And Response To The Survey 6
Respondent’s Company Or Organisational Origin 7 Respondent’s Geographic Origin 8
Respondent’s Job Role 9
Ion Channel Research Activities Undertaken By Respondents 10
Classes of Ion Channels of Most Interest to Respondents 11
Classes of Ion Channels Most Difficult To Screen 12
Number Of Ion Channel Drug Discovery Programs Under Investigation (1) 13
Number Of Ion Channel Drug Discovery Programs Under Investigation (2) 14
Primary Drivers For Initiating A New Ion Channel Program 15
Use Of APC Technologies In Different Drug Discovery Areas 16
Compound Library Size Tested Using An APC Platform 17
Number Of APC Well Processed Per Year Using An APC Platform 18
Summary of Survey Findings (1) 19
Proportion Of Different Cell Types Used In APC Assays 21
APC Platforms Respondents Currently Have Access To 22
Preferred Vendor’s APC System For Various Criteria 23
Likelihood Will Purchase A New APC Platform Over The Next Few Years 24
Number Of Units Of A New APC Platform Respondents Might Purchase 25
APC Platforms Most Appealing For Future Purchasing 26
Factors Which Would Most Influence Purchasing Of APC Platform 27
APC Consumables Budget 28
APC Market Estimates (1) 29
APC Market Estimates (2) 30
How APC Consumable Budget For Ion Channel Testing Is Determined 31
Factors Preventing Greater Use Of APC Consumables 32
How New 384 APC Platforms May Affect Screening Activities 33
APC Consumable Pricepoints For New 384-Well APC Screening Platforms 34
Awareness of FDA CIPA Working Group And Impact On Safety Assays 35
Summary of Survey Findings (2) 36
New APC System for 2D Cellular Networks (Technology Description) 38
Technologies Investigated To Obtain Information On Cell-Cell Communication With 2D Cellular Networks (1) 39 Technologies Investigated To Obtain Information On Cell-Cell Communication With 2D Cellular Networks (2) 40 What Respondents Most Want To Analyze With A New APC System For 2D Cellular Networks 41
Applications Most Suited To An APC System For 2D Cellular Networks 42
Preferred Cell Types For An APC Analysis System For 2D Cellular Networks 43
Main Advantages Of An APC System For 2D Cellular Networks 44
Potential Disadvantages Of An APC System For Adherent Cellular 2D Networks 45
Features Needed In A New APC System For Analysis Of Cellular 2D Networks 46
Patch Combinations Most Optimal For Respondent’s Research 47
Throughput Needed For Analysis 2D Cellular Networks 48
Preferred Route To Access A New APC System For Cellular 2D Networks 49
Reasonable Price To Pay For A New APC System For 2D Cellular Networks Networks 50
Likelihood Of Purchasing A New APC System For Cellular 2D Networks 51
Reasonable Price To Pay For APC Consumables For 2D Cellular Networks 52
Respondents Interested In More Info Or Testing The New APC System For 2D Cellular Networks 53
Summary of Survey Findings (3) 54

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Global Pregnancy Detection Card Market 2015-2019
    Published: 19-Nov-2014        Price: US $2500 Onwards        Pages: 71
    Pregnancy detection cards are diagnostic products that check for chemical markers related to pregnancy. The card or cassette format is one of the three categories under rapid pregnancy tests. The remaining two are the strip format and the midstream format. Pregnancy detection cards use the chromatographic immunoassay technique for the detection of hCG in urine to detect pregnancy. The developing placenta produces hCG, which is a glycoprotein hormone, soon after fertilization, and this helps in t......
  • Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) – Global Forecast to 2019
    Published: 13-Nov-2014        Price: US $4650 Onwards        Pages: 212
    The global ultrasound market is estimated to grow at a CAGR of 5.1% from 2014 to 2019. Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the ultrasound market in 2014, Asia-Pacific is poised to grow at the highest CAGR of 5.5% in the next five years.Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improvements and modernization of  healthcare infrastructure, government initiatives to have advan......
  • 2014-2018 Germany Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
    Published: 12-Nov-2014        Price: US $3000 Onwards        Pages: 121
    This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments Abbott Affymetrix Agilent Technologies Applied Gene Tech......
  • 2014-2018 Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers–Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $8500 Onwards        Pages: 500
    "New Frontiers in Point-of-Care/POC Clinical Chemistry and Immunodiagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape" is Venture Planning Group's new report, which provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Rationale The growing economic pressures on hos......
  • 2014-2018 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $2450 Onwards        Pages: 410
    This new study from Venture Planning Group contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testig for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years. Report Highlights Market shares of leading suppliers Business and technological trends in major markets Five-year test volume and sa......
  • 2014-2018 World Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country
    Published: 12-Nov-2014        Price: US $2450 Onwards        Pages: 15
    This report provides: Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country. Five-year test volume and sales forecasts by country. ......
  • 2014-2018 French Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies–Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
    Published: 12-Nov-2014        Price: US $6700 Onwards        Pages: 850
    This report presents a comprehensive analysis of the French molecular diagnostics market, including: Major issues pertaining to the French molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods. Ten-year test vo......
  • 2014-2018 UK Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
    Published: 12-Nov-2014        Price: US $4350 Onwards        Pages: 615
    This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights Business and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • 2014-2018 Italy Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
    Published: 12-Nov-2014        Price: US $3000 Onwards        Pages: 121
    This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new  products in R&D, collaborative arrangements, and business strategies. Competitive Assessments Abbott Affymetrix Agilent Technologies Applied Gene Tech......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs